Polymerase News and Research

RSS

The distribution and dynamics of microbial populations on surfaces within a clinical microbiology lab during the COVID-19 pandemic

Researchers evaluated the distribution of microbes on surfaces within a microbiology laboratory.

29 Jun 2022

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

IgA and IgG in human breast milk and blood were assessed for their activity against SARS-CoV-2 and SARS-CoV-1, as well as four other prevalent HCoVs.

28 Jun 2022

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Researchers performed genomic comparisons between alphacoronaviruses (αCoVs) and betacoronaviruses (βCoVs) originating from South Korean Bats.

28 Jun 2022

3rd COVID vaccine significantly reduced hospitalizations and deaths during Australia's 1st Omicron wave

Researchers compare vaccine effectiveness in people who received three doses of the COVID-19 vaccine as compared to those who received two doses.

27 Jun 2022

Infectious period in healthy, vaccinated adults with SARS-CoV-2 is limited, study finds

In January 2022, the U.S. shifted its guidelines to recommend isolation of five days from COVID-19 symptom onset, followed by an additional five days of mask wearing.

27 Jun 2022

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

27 Jun 2022

Review and case study illustrates the challenges of monkeypox

A new paper published in Travel Medicine and Infectious Disease reviews the history of this disease in and outside Africa, with special reference to its clinical difficulties.

27 Jun 2022

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Researchers presented the PREVENT-19 phase 3 trial findings on the effectiveness of the NVX-CoV2373 adjuvanted, recombinant S nanoparticle vaccine.

27 Jun 2022

Persistent fatigue post-COVID-19 in pregnant women

Researchers determine the factors and time duration associated with fatigue for pregnant women who had positive SARS-CoV-2 serology during delivery.

27 Jun 2022

Does fecal viral excretion provide insights into on GI symptoms of COVID-19?

Researchers discuss the physiopathological mechanisms associated with digestive symptoms associated with COVID-19.

27 Jun 2022

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.

24 Jun 2022

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Scientists have described the development of a modified A549 cell line that shows a robust expression of ACE2 and TMPRSS2 and high susceptibility to SARS-CoV-2 infection.

24 Jun 2022

Serologic testing captures missed children at risk for long Covid

A new study provides evidence of the utility of serologic testing in helping to pick up children with long Covid following missed diagnoses of COVID-19.

24 Jun 2022

Associations between maternal COVID-19 vaccination and hospitalization among infants

Researchers assessed the efficacy of maternal mRNA vaccinations during pregnancy against hospitalization for COVID-19 in infants aged <6 months.

24 Jun 2022

Symptomatology of long COVID among children below 14 years of age in Denmark

Researchers investigated long COVID symptoms among SARS-CoV-2-infected Danish children below 14 years of age.

24 Jun 2022

Characterization of SARS-CoV-2 Omicron persistence and infectivity among children

Researchers characterized the persistence and infectivity of SARS-CoV-2 Omicron among children.

24 Jun 2022

Epstein-Barr virus can reactivate in long COVID

In a recent study posted to the medRxiv* preprint server, researchers at the University of California, San Francisco, and Monogram Biosciences examined the connections between the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) and Epstein-Barr virus (EBV) reactivation.

23 Jun 2022

Polymerase News and Research

The distribution and dynamics of microbial populations on surfaces within a clinical microbiology lab during the COVID-19 pandemic

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

3rd COVID vaccine significantly reduced hospitalizations and deaths during Australia's 1st Omicron wave

Infectious period in healthy, vaccinated adults with SARS-CoV-2 is limited, study finds

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Review and case study illustrates the challenges of monkeypox

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Persistent fatigue post-COVID-19 in pregnant women

Does fecal viral excretion provide insights into on GI symptoms of COVID-19?

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Serologic testing captures missed children at risk for long Covid

Associations between maternal COVID-19 vaccination and hospitalization among infants

Symptomatology of long COVID among children below 14 years of age in Denmark

Characterization of SARS-CoV-2 Omicron persistence and infectivity among children

Epstein-Barr virus can reactivate in long COVID

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

The duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents

Mutation in SARS-CoV-2 nucleocapsid protein found to enhance replication and pathogenicity

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News